The novel NO redox sibling, nitroxyl (HNO), prevents cardiomyocyte hypertrophy and superoxide generation via cGMP

Documenti analoghi

• Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
  di: Lin, Eliane Q., et al.
  Pubblicazione: (2012)
• The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•
  di: Ritchie, Rebecca, et al.
  Pubblicazione: (2013)
• Nitroxyl, the novel redox sibling of NO, suppresses cerebrovascular NADPH oxidase
  di: Kemp-Harper, Barbara, et al.
  Pubblicazione: (2009)
• cGMP and cardiac hypertrophy
  di: Perera, Ruwan K, et al.
  Pubblicazione: (2015)
• The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
  di: Irvine, Jennifer C., et al.
  Pubblicazione: (2012)